Muscular Dystrophy Efficacy Studies

JAX performs efficacy studies on mouse models for these diseases: C57BL10.mdx and D2.mdx for DMD, DyW for CMD1A, and A/J for dysferlinopathy. Additional mouse mutants are available for studies.


Ground MD, et al. 2008. Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol Dis 31:1-19 PMID: 18499465